10-88596880-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001010939.3(LIPJ):āc.667A>Gā(p.Ile223Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000502 in 1,593,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001010939.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIPJ | NM_001010939.3 | c.667A>G | p.Ile223Val | missense_variant | 8/11 | ENST00000371939.7 | NP_001010939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIPJ | ENST00000371939.7 | c.667A>G | p.Ile223Val | missense_variant | 8/11 | 1 | NM_001010939.3 | ENSP00000361007.3 | ||
LIPJ | ENST00000531458.1 | c.168+464A>G | intron_variant | 3 | ENSP00000434211.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151736Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248218Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134352
GnomAD4 exome AF: 0.00000416 AC: 6AN: 1441722Hom.: 0 Cov.: 27 AF XY: 0.00000418 AC XY: 3AN XY: 718072
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151854Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.667A>G (p.I223V) alteration is located in exon 8 (coding exon 6) of the LIPJ gene. This alteration results from a A to G substitution at nucleotide position 667, causing the isoleucine (I) at amino acid position 223 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at